Baader Bank Aktiengesellschaft’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Baader Bank Aktiengesellschaft's BIIB Position: Q2 2026 in Review
Baader Bank Aktiengesellschaft reduced its Biogen (BIIB) stake by 7.2% in Q2 2026, selling an estimated $427K and leaving 28,568 shares worth $6.17M. The position accounts for 0.46% of the portfolio, ranked #52.
Baader Bank Aktiengesellschaft first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.83M in Q3 2025. 1,042 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Baader Bank Aktiengesellschaft held 28,568 shares of Biogen worth $6.17M as of Q2 2026.
- Baader Bank Aktiengesellschaft sold 2,233 Biogen shares in Q2 2026, an estimated $427K.
- Biogen made up 0.46% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #52 holding.
- Baader Bank Aktiengesellschaft first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
- Baader Bank Aktiengesellschaft's Biogen position peaked at $7.83M in Q3 2025.
- 1,042 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.